Duality Advisers’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-106,853
Closed -$1.71M 624
2022
Q4
$1.71M Buy
106,853
+1,263
+1% +$20.6K 0.2% 186
2022
Q3
$1.66M Buy
+105,590
New +$2.04M 0.18% 221
2021
Q3
Sell
-237,968
Closed -$4.34M 594
2021
Q2
$4.34M Buy
+237,968
New +$5.55M 0.39% 65
2021
Q1
Sell
-72,022
Closed -$1.45M 577
2020
Q4
$1.45M Buy
+72,022
New +$1.51M 0.11% 280
2020
Q3
Sell
-91,199
Closed -$2.17M 597
2020
Q2
$2.17M Buy
+91,199
New +$2.11M 0.2% 143
2020
Q1
Sell
-75,939
Closed -$1.34M 112
2019
Q4
$1.34M Sell
75,939
-17,071
-18% -$289K 0.08% 241
2019
Q3
$1.65M Buy
+93,010
New +$1.88M 0.09% 215

Other funds holding EXEL

Duality Advisers's EXEL Position: Q1 2023 in Review

Duality Advisers sold out of Exelixis (EXEL) in Q1 2023, closing a stake of 106,853 shares — an estimated $1.71M sold.

Duality Advisers first reported a position in EXEL in Q3 2019 and held it in 7 quarters. The position peaked at $4.34M in Q2 2021. 363 funds tracked by Wall St. Rank hold EXEL as of Q1 2023.

  • Duality Advisers reported no remaining Exelixis position as of Q1 2023 after selling out during the quarter.
  • Duality Advisers sold 106,853 Exelixis shares in Q1 2023, an estimated $1.71M.
  • Duality Advisers first reported a position in Exelixis in Q3 2019 and held it in 7 quarters.
  • Duality Advisers's Exelixis position peaked at $4.34M in Q2 2021.
  • 363 funds tracked by Wall St. Rank held Exelixis as of Q1 2023.

Based on Duality Advisers's 13F filing for Q1 2023, filed 27 Jun 2023.